<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Item #</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">3904</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">3</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">NAACCR</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2018</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">18</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1779 - 1781</td>
    </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.oncotypeDxRecurrenceScoreInvasiv<br/><br/>


<div class='content chap10-para-head'><strong><strong>Description</strong></strong></div>
<div class='content chap10-para'>Oncotype Dx Recurrence Score-Invasive is a numeric score of a genomic test to predict the likelihood of distant recurrence of invasive breast cancer based on the assessment of 21 genes.</div>
<div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div>
<div class='content chap10-para'>Oncotype Dx Recurrence Score-Invasive is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div>
<div class='content chap10-para'><strong>Codes</strong></div>
<div class='content chap10-para'>
    <table>
        <tr class='code-row'>
            <td class='code-nbr'>0-100</td>
            <td class='code-desc'>Enter actual recurrence score between 0 and 100</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>XX4</td>
            <td class='code-desc'>Stated as less than 11</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>XX5</td>
            <td class='code-desc'>Stated as equal to or greater than 11</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>XX6</td>
            <td class='code-desc'>Not applicable: in situ case</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>XX7</td>
            <td class='code-desc'>Test ordered, results not in chart</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>XX9</td>
            <td class='code-desc'>Not documented in medical record<br/>
                Oncotype Dx Recurrence Score-Invasive not assessed or unknown if assessed
            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'></td>
            <td class='code-desc'></td>
        </tr>
    </table>
</div>
<div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div>